2
Seven new technologies selected to help transform NHS care and speed up diagnosis
Artificial intelligence tools that could revolutionise patient care are being trialled in phase 2 of the Medicines and Healthcare products Regulatory Agency’s (MHRA) AI Airlock programme.
Seven manufacturers developing AI-powered healthcare technologies have been chosen to take part in the next stage of the initiative, which provides a controlled environment to test tools safely, assess their effectiveness and explore regulatory pathways.
The selected technologies include tools for clinical note taking,…